Building processes and maintaining data integrity: Your Pharma 4.0 journey

Dive into the nuances of data integrity as experts from Blue Mountain and Barry-Wehmiller Design Group discuss the challenges organizations face and how they overcome them

Available on: May 7, 2024 

2:00 PM ET / 1:00 PM CT / 11:00 AM PT / 6:00 PM GMT 

Register Today!
Duration: 1 hour 


Pharma 4.0 is focused on realizing the full potential of digitization so organizations can drive faster innovation and deliver higher quality therapies to patients. Data integrity is an essential component for any successful transition to the increasingly advanced and sophisticated Pharma 4.0 era. By ensuring accuracy and consistency of all data stored within a system, organizations can benefit from improved decision making, increased efficiency and enhanced compliance.

Pharma 4.0 is not an end-state but rather a journey. This webinar delves into the nuances of data integrity along this journey by discussing the challenges organizations face and how to overcome them.  Additionally, it shines light on how organizations can find a starting point that makes sense for them. Attendees will learn about:

  •           Pharma 4.0 — the benefits and why it’s a journey rather than an end state
  •           Why data integrity is essential for this journey
  •           Why Pharma 4.0 doesn’t need to be over-complicated and what building blocks need to be put in place
  •          Data standardization as a core mindset, and how to begin to clean up data


Ginny Lee, Executive Director of Global Services, Blue Mountain

With over 20 years in the life science industry, Ginny is the Director of Professional Services at Blue Mountain. She spearheads strategic initiatives, optimizing implementation, project management, and education services for GMP compliance. Leading the Delivery Services and Customer Success teams, Ginny's expertise benefits Blue Mountain's extensive customer base. With 8 years at Blue Mountain and prior roles at pharmaceutical giants like Merck and GlaxoSmithKline, Ginny brings a wealth of experience to her role.

Jennifer Chang, QA Intelligence Specialist, Blue Mountain

Jennifer is a seasoned quality professional with over a decade of experience in pharmaceutical manufacturing, bringing specialized expertise in quality systems, regulatory compliance, software quality assurance, and risk management. Through her role as QA Intelligence Specialist, Jennifer leverages profound industry knowledge to promote ongoing compliance and continuous improvement at Blue Mountain. Jennifer employs a practical approach to decrypt intricate regulatory guidance, and assists our customers in navigating a complex and evolving compliance landscape.

Aaron Hubbell, Director, Barry-Wehmiller Design Group

With over 20 years in the Biopharmaceutical industry, Aaron excels at building and leading teams, developing and implementing technical and compliance solutions, and leading business development and sales efforts. Key interest areas include risk-based commissioning and qualification, quality risk management, human performance and error prevention, and operational and process improvement.


Andrea Corona, Senior Editor, Pharma Manufacturing

Andrea Corona serves as the Senior Editor of Pharma Manufacturing, and is responsible for creation of editorial content, moderating webinars, and co-hosting the "Off script" podcast. Her editorial journey started as an as Associate Editor at Biocompare, an online platform providing life scientists with product information, industry news, articles, and other resources to support scientists in their work. Before this, she was a Digital Producer at Science Friday, focusing on adapting radio segments for the web and handling social media. Andrea earned her Bachelor's degree in Journalism and Biology from Purchase College, SUNY. 

Sponsored by: